Luye Pharma Group Employee Directory
Pharmaceutical ManufacturingShanghai, China501-1000 Employees
Luye Pharma serves a broad international market, operating in more than 80 countries and regions and targeting four major therapeutic areas: oncology, cardiovascular, metabolism, and CNS. A notable recent development is the launch of Zepzelca (lurbinectedin) for small cell lung cancer in Hong Kong and Macao, reflecting ongoing expansion of access to its medicines. The company has engaged in strategic partnerships to improve distribution and accessibility, such as BeiGene’s collaboration to commercialize Goserelin Microspheres in mainland China. This combination of in-house innovation, a diverse product portfolio, and global partnerships positions Luye Pharma as a mid-sized player seeking to bring advanced formulations and therapies to patients worldwide.